COX-1 and COX-3 inhibitors

Area of Science:

• Pharmacology
• Biochemistry

Background:

• Aspirin exhibits dose-dependent effects: low doses alleviate pain and fever, while higher doses are needed for anti-inflammatory action.
• Cyclooxygenase (COX) enzymes, particularly COX-1 and COX-2, are implicated in aspirin's diverse pharmacological activities.
• The precise mechanisms and sites of action for aspirin's analgesic, antipyretic, and anti-inflammatory effects are still under investigation.

Purpose of the Study:

• To investigate the roles of cyclooxygenase (COX) enzymes in mediating the analgesic, antipyretic, and anti-inflammatory actions of aspirin.
• To compare the peripheral analgesic effects of an aspirin-like drug (diclofenac) with a centrally acting analgesic (paracetamol).
• To explore potential sites of action for aspirin's antipyretic effects, including hypothalamic endothelial cells and peripheral vagal afferents.

Main Methods:

• Utilized the mouse stretching test to compare the analgesic effects of diclofenac and paracetamol.
• Reviewed existing literature on the involvement of COX-1, COX-2, and potentially COX-3 in fever and inflammation.
• Considered studies involving gene-deleted mice (e.g., COX-2 knockout) to understand the role of specific COX enzymes in fever.

Main Results:

• Confirmed the peripheral nature of analgesic action for aspirin-like drugs (diclofenac) in the mouse stretching test.
• Lipopolysaccharide (LPS)-induced fever is significantly reduced in mice lacking the COX-2 gene.
• COX-1 gene deletion may also impact temperature regulation and mediate fever in non-infectious conditions.

Conclusions:

• Inhibition of COX-1 may be primarily responsible for aspirin's pain-relieving and fever-reducing effects.
• COX-2 inhibition is likely key to aspirin's anti-inflammatory properties.
• Aspirin's antipyretic action might involve COX-3 in the hypothalamus or COX-1 near peripheral sensory receptors, with potential involvement of both.